Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.

Krauth, MT, Burgstaller, S, Buxhofer-Ausch, V, Gastl, G, Geissler, K, Keil, F, Krippl, P, Melchardt, T, Petzer, A, Rumpold, H, Sliwa, T, Wöhrer, S, Wölfler, A, Gisslinger, H. Wien Klin Wochenschr. 2018.

Factor VII deficiency in major artery occlusion stroke.

Pikija, S, Gampenrieder, SP, Millesi, K, Pilz, G, Weis, S, Mutzenbach, JS. Am J Hematol. 2018, 93(6):843-845.

Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity.

Wolf, M, Aglas, L, Twaroch, TE, Steiner, M, Huber, S, Hauser, M, Parigiani, MA, Hofer, H, Ebner, C, Bohle, B, Briza, P, Neubauer, A, Stolz, F, Wallner, M, Ferreira, F. J Allergy Clin Immunol. 2018, 141(4):1488-1491.e5.

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.

Egle, A, Steurer, M, Melchardt, T, Weiss, L, Gassner, FJ, Zaborsky, N, Geisberger, R, Catakovic, K, Hartman, TN, Pleyer, L, Voskova, D, Thaler, J, Lang, A, Girschikofsky, M, Petzer, A, Greil, R. Ann Hematol. 2018.

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.

Asamer, E, Szkandera, J, Gibiser, P, Lembeck, AL, Stojakovic, T, Kornprat, P, Lackner, C, Winder, T, Schlick, K, Stoger, H, Gerger, A, Pichler, M, Stotz, M. WIEN KLIN WOCHENSCHR. 2018, 130(19-20): 569-574.

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).

Rinnerthaler, G, Gampenrieder, SP, Petzer, A, Burgstaller, S, Fuchs, D, Rossmann, D, Balic, M, Egle, D, Rumpold, H, Singer, CF, Bartsch, R, Petru, E, Melchardt, T, Ulmer, H, Mlineritsch, B, Greil, R. BMC Cancer. 2018, 18(1): 1074.

Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia.

Gassner, FJ, Schubert, M, Rebhandl, S, Spandl, K, Zaborsky, N, Catakovic, K, Blaimer, S, Hebenstreit, D, Greil, R, Geisberger, R. Mol Cancer Res. 2018, 16(3):428-438.

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.

Ball, B, Komrokji, RS, Ades, L, Sekeres, MA, DeZern, AE, Pleyer, L, Vey, N, Almeida, A, Germing, U, Cluzeau, T, Platzbecker, U, Gore, SD, Fenaux, P, Prebet, T. BLOOD ADV. 2018, 2(16): 2063-2071.

RNA Trans-Splicing Modulation via Antisense Molecule Interference.

Liemberger, B, Piñón Hofbauer, J, Wally, V, Arzt, C, Hainzl, S, Kocher, T, Murauer, EM, Bauer, JW, Reichelt, J, Koller, U. Int J Mol Sci. 2018, 19(3).

Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.

Fitzal, F, Bjelic-Radisic, V, Knauer, M, Steger, G, Hubalek, M, Balic, M, Singer, C, Bartsch, R, Schrenk, P, Soelkner, L, Greil, R, Gnant, M. Ann Surg. 2018.